Libertyville, IL, United States of America

Emily O Dumas

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Emily O. Dumas

Introduction

Emily O. Dumas, an accomplished inventor based in Libertyville, IL, has made significant contributions to the field of healthcare with her innovative approaches to treating Hepatitis C Virus (HCV). With a remarkable portfolio of 9 patents, her work showcases her commitment to developing effective therapies that improve patient outcomes.

Latest Patents

Dumas's most recent patents focus on groundbreaking methods for treating HCV. One notable invention features interferon-free therapies aimed at shortening treatment durations to no more than 12 weeks. The therapies involve administering a combination of at least two direct-acting antiviral agents along with ribavirin to effectively treat subjects suffering from HCV infection. Additionally, another patent presents interferon- and ribavirin-free therapies, which include administering direct-acting antiviral agents and an inhibitor of cytochrome P450 (such as ritonavir) to achieve successful treatment outcomes.

Career Highlights

Dumas has had an impressive career, marked by her tenure at leading pharmaceutical companies such as AbbVie Inc. Her work in these esteemed organizations has been vital in developing therapeutics that address pressing healthcare challenges, particularly in the realm of viral infections.

Collaborations

Throughout her career, Emily O. Dumas has collaborated with esteemed colleagues, including Barry M. Bernstein and Rajeev M. Menon. These collaborations have enriched her research and fueled her innovative spirit, enabling her to push the boundaries of biotechnology and pharmaceutical development.

Conclusion

Emily O. Dumas stands as a testament to the impact that ingenuity and dedication can have in the field of healthcare. Her patents not only reflect her innovative thinking but also her unwavering commitment to improving treatment options for patients with HCV. As she continues her journey in the realm of medical innovation, the future looks bright for her contributions to healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…